Continua publishes open health tools on website

Continua Health Alliance, a non-profit, open-industry organization of healthcare and technology companies, has announced new additions to its open source clearinghouse to encourage innovation by entrepreneurs, small businesses, students and universities working on health IT projects.

The alliance published four primary components on open health tools, its online clearinghouse, and also created a developer resources section on its website that contains tools supporting certification according to its design guidelines for personal connected health devices and systems, according to a June 4 Continua press release. The alliance also announced that it is working to publish open source code covering all Continua end-to-end interfaces.

"Providing demonstration code to the public will help to stimulate innovation and new products in the market, and support entrepreneurs and students interested in developing or certifying products in personal connected health," Chuck Parker, executive director, Continua Health Alliance, said in a statement.

The following components are now available:

  • WAN IEEE-20601 encoder implementation, written in Java
  • WAN sender and receiver implementation, written in Java
  • Binary object package of the core WAN implementation suitable for mobile implementations, written in Java
  • WAN encoder and sender android example, written in Java

According to the announcement, device profiles covered in the code include all IEEE -11073-104xx devices inclusive of blood pressure monitors, glucose meters, pulse oximeters and thermometers.

The components are accessible here and the newly created developers’ resources section is viewable here.

Around the web

CMS finalized a significant policy change when it increased the Medicare payments hospitals receive for performing CCTA exams. What, exactly, does the update mean for cardiologists, billing specialists and other hospital employees?

Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio.

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.